Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration

Author： Xia Zhengyuan Kuo Kuo-Hsing McNeill John H Ansley David M

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.83, Iss.3, 2005-03, pp. : 259-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis

By Hogaboam C.M. Muller M.J. Collins S.M. Hunt R.H.

European Journal of Pharmacology, Vol. 309, Iss. 3, 1996-08 ,pp. : 261-269

Elsevier

Access to resources Recommend Favorite

Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat

By Xing-San L. Qing-Dong W. John P.

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

Bosentan: a dual endothelin receptor antagonist

By Roux Sébastien Rubin Lewis J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 991-1002

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist

By Jasper Dingemanse Paul L.M. van Giersbergen

Clinical Pharmacokinetics, Vol. 43, Iss. 15, 2004-01 ,pp. : 1089-1115

Adis International

Access to resources Recommend Favorite

Bosentan, a dual endothelin receptor antagonist, activates the pregnane X nuclear receptor

By van Giersbergen P.L.M. Gnerre C. Treiber A. Dingemanse J. Meyer U.A.

European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite